Evidence map›Paper›PMID 42256547›Full record

ArticleHemaSphere2026

Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study.

Nicola Polverelli, Annalisa Chiappella, Cristiana Carniti, Pierluigi Zinzani, Maurizio Musso, Maria Chiara Tisi, Fabio Ciceri, Ilaria Cutini, Armando Santoro, Patrizia Chiusolo and 25 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Nicola PolverelliUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.ORCID https://orcid.org/0000-0001-6297-9697
Annalisa ChiappellaDivision of Hematology and Stem Cell Transplantation Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy.
Cristiana CarnitiDivision of Hematology and Stem Cell Transplantation Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy.
Pierluigi ZinzaniIRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli" Bologna Italy.ORCID https://orcid.org/0000-0002-2112-2651
Maurizio MussoOnco-Hematology Unit and BMT La Maddalena Hospital Palermo Italy.
Maria Chiara TisiHematology Unit San Bortolo Hospital, AULSS 8 Berica Vicenza Italy.
Fabio CiceriIRCCS Ospedale San Raffaele Milano Milano Italy.
Ilaria CutiniSOD Ematologia Azienda Ospedaliera Universitaria Careggi Firenze Italy.
Armando SantoroDepartment of Oncology and Hematology, IRCCS Humanitas Research Hospital Transplantation Unit Milano Italy.
Patrizia ChiusoloDipartimento di Scienze di Laboratorio ed Ematologiche-Fondazione Policlinico Universitario Agostino Gemelli-IRCCS Roma Italy.
Anna Maria BarbuiAzienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo Italy.
Mirko FarinaUnit of Blood Disease and Bone Marrow Transplantation, and Unit of Hematology University of Brescia, ASST Spedali Civili di Brescia Brescia Italy.
Livia DonzelliHematology Department of Translational and Precision Medicine University Sapienza Roma Roma Italy.
Lucia BrunelloHematology Department A.O.U. SS Antonio & Biagio and C. Arrigo Alessandria Italy.
Massimo MartinoStem Cell Transplantation and Cellular Therapies Unit (CTMO) Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Reggio Calabria Italy.
Mauro KramperaHematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine (DIMI) University of Verona Verona Italy.
Alessia CastellinoDepartment of Hematology Santa Croce e Carle Hospital Cuneo Italy.
Giovanni GrilloDepartment of Hematology ASST Grande Ospedale Metropolitano Niguarda Milano Italy.
Barbara BottoDivision of Hematology and Allogeneic Stem Cell Transplant Unit A.O.U. Città della Salute e della Scienza Turin Italy.
Jacopo OlivieriHematology and Stem Cell Transplantation Unit, Udine University Hospital Azienda Sanitaria Universitaria Friuli Centrale Udine Italy.
Michele ClericoHematology, Department of Molecular Biotechnologies and Health Sciences University of Torino Torino Italy.
Pellegrino MustoDepartment of Precision and Regenerative Medicine and Ionian Area "Aldo Moro" University School of Medicine Bari Italy.
Attilio OlivieriAzienda Ospedali Riuniti di Ancona, Department of Hematology Ancona University Ancona Italy.
Antonio BianchessiUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Irene DefrancescoUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Giulia LosiUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Caterina ZerbiUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Gianluca MartiniUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.ORCID https://orcid.org/0009-0002-3820-0908
Elisa RoncoroniUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Manuel GottiUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Maria Grazia BeneventoUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Alessia TaurinoUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Anna FedinaData Office Fondazione Italiana Linfomi Alessandria Italy.
Paolo CorradiniDivision of Hematology and Stem Cell Transplantation Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy.
Luca ArcainiUnit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.ORCID https://orcid.org/0000-0002-9504-991X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42256547
PMCPMC13240038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.